Alzheimer's Disease Clinical Trials in New York

Showing 81-100 of 137 trials

A Study of Brain Aging in Vietnam War Veterans

NCT01687153

Traumatic brain injury (TBI) and post traumatic stress disorder (PTSD) are common combat related problems and may be associated with a greater risk of Alzheimer's disease (AD). The purpose of this study is to examine the possible connections between TBI and PTSD, and the signs and symptoms of AD on Veterans as they age. The information collected will help to learn more about how these injuries may affect Veterans of the Vietnam War as they grow older, as well as Veterans of the current wars in Iraq and Afghanistan, who also have these types of combat related injuries.

Traumatic Brain InjuryPost Traumatic Stress DisorderAlzheimer's Disease+1 more

University of Southern California289 participantsStarted Oct 2012

Sun City, Arizona, United States • Irvine, California, United States • La Jolla, California, United States +16 more locations

COMPLETEDPHASE3< 1 mile

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

NCT02547818

This is a global Phase III, randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The protocol is designed to determine whether ALZT-OP1 combination treatment (ALZT-OP1a + ALZT-OP1b) will slow down, arrests, or reverse cognitive and functional decline, in subjects with evidence of early stage Alzheimer's disease (AD).

Alzheimer's Disease

AZTherapies, Inc.620 participantsStarted Sep 2015

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +118 more locations

A Study of Brain Aging in Vietnam War Veterans

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Alzheimer's Disease Trials in Other Cities

A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection

2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

A Phase I Study for Safety and Tolerability of AL002.

Brain Sleep Deprivation MRI Effects (BEDTIME)

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Northern Manhattan Caregiver Intervention Project

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

Aricept to Improve Functional Tasks in Vascular Dementia

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Randomized Evaluation of Default Access to Palliative Services

18F-AV-1451 Autopsy Study

Cholinesterase Inhibitor Discontinuation

Other Conditions in New York